GKCC, LLC 4
4 · Elicio Therapeutics, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Chudnovsky Yekaterina
Director10% Owner
Transactions
- Purchase
Pre-Funded Common Stock Purchase Warrant
2024-03-19$5.81/sh+1,032,702$5,999,999→ 1,032,702 total(indirect: By LLC)Exercise: $0.01→ Common Stock (1,032,702 underlying)
Footnotes (3)
- [F1]Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained.
- [F2]The Pre-Funded Warrants do not have an expiration date.
- [F3]Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.